DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Livingstone E, Zimmer L, Vaubel J et al.
BRAF, MEK and KIT inhibitors for melanoma: adverse events and their management.
Chin Clin Oncol 2014;
3: 29
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.